Skip to main content
2021 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
  1. Home
  2. Full Schedule

Full Schedule

Full Schedule

  • On Demand
  • Achieving Virtual Bioequivalence with PBPK in Lieu of Clinical Studies

    Partner Presentation Speaker: Nikunjkumar Patel, PhD, MS (Pharm), BPharm – Certara

    Formulation and Delivery

  • Binary Solvent Mixtures to Simulate Use Conditions for Medical Devices

    Partner Presentation Speaker: Kevin Rowland, MS – Jordi Labs

    Manufacturing and Analytical Characterization

  • Bioanalytical Perspectives on Microsampling

    Tech Challenge Speaker: Jason Watts, PhD – Alturas Analytics, Inc.

    Bioanalytics

  • CARTs: New Materials for Gene Delivery

    Partner Presentation Speaker: Maaike Everts, PhD – Evonik Health Care

    Partner Presentation Speaker: Robert M. Waymouth, PhD – Stanford University

    Formulation and Delivery

  • Confidently Detect Nitrosamines in Sartans, Ranitidine and Metformin-Based Drugs

    Partner Presentation Speaker: Parul Angrish, PhD – Agilent Technologies, Inc.

    Manufacturing and Analytical Characterization

  • Connecting to Communicate : Critical Skills for Leaders Post-pandemic

    Career Center Speaker: Lisa Scott, CCC-SLP – Accentuate

    Career Development

  • Creating a Culture that Cultivates and Sustains Innovation and Entrepreneurship

    Career Center Moderator: David Feola, PharmD, PhD – University of Kentucky College of Pharmacy

    Career Center Speaker: Deanna L. Kroetz, PhD – University of California San Francisco

    Career Center Speaker: Jamie Moore, PhD – Genentech, Inc.

    Career Center Speaker: Otilia M. Koo, PhD – Bristol-Myers Squibb Company

    Career Development

  • Demonstrating the Power of Controlled-Expansion scCO2 Applied to Drug Development

    Tech Challenge Speaker: Satu Lakio, Phd – Nanoform Finland Ltd.

  • Developing Control Strategies for Impurities - Contract Lab Experience

    Partner Presentation Speaker: Ashok Kumar, PhD – Sannova Analytical Inc.

    Manufacturing and Analytical Characterization

  • Diversity and Inclusion-How Asian Pharmaceutical Scientists Adapt to the Environment?

    Career Center Speaker: Kim Huynh-Ba, MS, PMP, FAAPS – Pharmalytik

    Career Center Speaker: Jianmei D. Kochling, PhD, MBA. – Sanofi

    Career Center Speaker: Otilia M. Koo, PhD – Bristol-Myers Squibb Company

    Career Center Speaker: Kin Tang, PhD – Genentech

    Career Center Speaker: Min Xia, PhD – Alan Laboratories, Inc.

    Career Center Speaker: Ganapathy Mohan, PhD – Merck & Co., Inc.

    Career Development

  • Dose Design Process to Create Better Treatments

    Partner Presentation Speaker: Lisa Caralli, B.S. – Catalent, Inc.

    Formulation and Delivery

  • Drug Repurposing: Pathway for Innovation in Drug Formulation and Delivery

    Partner Presentation Speaker: Anil Kane, Ph.D., MBA, PhD – Thermo Fisher Scientific

    Formulation and Delivery

  • Effective Research Presentations During Interview

    Career Center Moderator: Rajesh R. Patil, Ph.D. – Pfizer Inc.

    Career Center Speaker: Saileta Prabhu, PhD – Takeda Pharmaceuticals, Inc.

    Career Center Speaker: Marian Gindy, PhD – Merck & Co., Inc.

    Career Center Speaker: Debra T. Auguste, PHD – Northeastern University

    Career Center Speaker: Yow-Ming C. Wang, PhD – US Food and Drug Administration, Invited

    Career Development

  • Emerging Technologies for Analytical Characterization of Next Generation Biotherapeutics

    Partner Presentation Speaker: Paula Orens, MS – SCIEX

    Partner Presentation Speaker: Steven Calciano, MS – SCIEX

    Manufacturing and Analytical Characterization

  • Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation

    Partner Presentation Speaker: Nitin Swarnakar, PhD – BASF Corporation

    Partner Presentation Speaker: Lindsay M. Johnson, PhD – BASF Corporation

    Preclinical Development

  • Enhancing API Dissolution Using Lipid-Based Solid-Dose Delivery

    Partner Presentation Speaker: Anthony Carpanzano, Director of R&D at JRS PHARMA LP, Adjunct Professor of Pharmaceutics at Long Island University and Licensed Pharmacist – JRS PHARMA LP

    Formulation and Delivery

  • Formulation Design for Tablets with a Novel Fit-for-Purpose All-in-One Excipient

    Partner Presentation Speaker: Joao Marcos C. Assis – BASF Corporation

    Formulation and Delivery

  • Future Leaders: Join the Conversation with our Veteran Leaders

    Career Center Speaker: Russell Weiner, PhD – Bill and Melinda Gates Foundation

    Career Center Speaker: Carmen Fernandez-Metzler, PhD – Pharma Cadence Analytical Services, LLC

    Career Center Speaker: Faye Vazvaei, M.S. – Merck & Co., Inc.

    Career Center Moderator: Ngoc Kelly Pham, BS – Duquesne University

    Career Center Moderator: Padmanabhan Eangoor, PhD – Merck & Co., Inc.

    Career Development

  • Generic Human IgG assays for reuse of nonhuman primates

    Tech Challenge Speaker: Kelly S. Colletti, PhD, MBA – Charles River Laboratories

    Preclinical Development

  • Hot Topic: “Big Data” and Neuropharmacology: Where are we now?

    Discovery and Basic Research

  • Hot Topic: Bioanalytics – Biomolecular

    Bioanalytics – Biomolecular

  • Hot Topic: Bioanalytics – Chemical

    Bioanalytics – Chemical

  • Hot Topic: Bioequivalence Evaluation and Use of PBPK Modeling in Pediatrics

    Clinical Pharmacology – Chemical

  • Hot Topic: Dissolution Best Practices – Meeting Chinese Pharmacopeia Requirements

    Manufacturing and Analytical Characterization

  • Hot Topic: Engineering Microbial Living Therapeutics

    Discovery and Basic Research

  • Hot Topic: Manufacturing and Analytical Characterization – Biomolecular

    Manufacturing and Analytical Characterization – Biomolecular

  • Hot Topic: Manufacturing and Analytical Characterization – Chemical

    Manufacturing and Analytical Characterization – Chemical

  • Hot Topic: mRNA Therapeutics for Pulmonary Diseases

    Hot Topic Speaker: Shrirang Karve, PhD – Translate Bio

    Preclinical Development – Chemical

  • Hot Topic: Potential and Promise of Cytokine Based Cancer Immunotherapy: Design, Development

    Preclinical Development – Biomolecular

  • Hot Topic: Role of Model Informed Drug Development in Developing Vaccines

    Clinical Pharmacology – Biomolecular

  • Hot Topic: Solid Dispersions and Crystallinity

    Hot Topic Speaker: Lynne S. Taylor, PhD – Purdue University

    Formulation and Delivery – Chemical

  • Introduction to R Speaks NLME (RsNLME) and Example Use Cases
  • Job Switch Checklist: To Do List for Career Transition

    Career Center Moderator: Shraddha Thakkar, PhD – US Food and Drug Administration

    Career Center Moderator: Brian Dow, PhD – Janssen Research & Development, LLC

    Career Development

  • Keynote: Lessons Learned from the Commercialization of Continuous Manufacturing and Process Analytical Technology: How Can We Enable the New Modalities?

    Keynote Speaker: Edward M. Atkinson, PhD – Vertex Pharmaceuticals

    Manufacturing and Analytical Characterization – Chemical

  • Keynote: Advances in Process Control, Modeling and Analytics in Pharmaceutical Manufacturing – A Regulatory Perspective

    Keynote Speaker: Stelios C. Tsinontides, PhD – OPQ/CDER, FDA, Invited

    Manufacturing and Analytical Characterization – Chemical

  • Keynote: An Update on the Use of Physiologically Based Pharmacokinetic Modeling of Transporters: Predicting DDI, Non-Linearity and Target Tissue Exposure from in vitro to in vivo

    Keynote Speaker: Yuichi Sugiyama, PhD – Josai International University School of Pharmacy

    Clinical Pharmacology – Chemical

  • Keynote: Bioanalysis and Biomarker Sample Logistics Challenges in Global Studies

    Keynote Speaker: Patrick Bennett, M.S. – PPD Development, LP

    Bioanalytics – Chemical

  • Keynote: Building Targeted Protein Degradation Community

    Keynote Speaker: Milka Kostic, PhD – Dana-Farber Cancer Institute

    Discovery and Basic Research

  • Keynote: Challenges and Advances in the Modern Bioanalytical Lab: Working Across Modalities and Enabling a Quantitative Understanding of Biology

    Keynote Speaker: Daniel S. Spellman, PhD – Merck Research Laboratories

    Bioanalytics – Biomolecular

  • Keynote: Clinical Pharmacology and Immunogenicity Considerations of Novel Modalities

    Keynote Speaker: Amita Joshi, PhD – Genentech, Inc.

    Clinical Pharmacology

  • Keynote: Computational Systems Biology Approach for Enhancing Preclinical-to-Clinical Translation

    Keynote Speaker: Douglas Lauffenburger, PhD – MIT

    Preclinical Development – Biomolecular

  • Keynote: Critical Roles of Excipients in the Development of Generic Drug Products

    Keynote Speaker: Robert Lionberger, PhD – US Food and Drug Administration, Invited

    Formulation and Delivery – Chemical

  • Keynote: Designing and Building the Next Generation of Vaccines

    Keynote Speaker: Derek O'Hagan, PhD – GlaxoSmithKline plc

    Formulation and Delivery – Biomolecular

  • Keynote: Development of Long-Acting Injectables

    Keynote Speaker: Rene Holm, PhD – University of Southern Denmark

    Formulation and Delivery – Chemical

  • Keynote: Drug Efficacy, Safety and Dosing Information for All Patients Regardless of Personal Disease and Characteristic Frequency

    Keynote Speaker: Bob Powell, PharmD – None

    Clinical Pharmacology – Biomolecular

  • Keynote: Engineering Better Biologics: Does Nature Know Best?

    Keynote Speaker: Anne S. DeGroot, MD – EpiVax, Inc.

    Discovery and Basic Research

  • Keynote: Evolving Best Practices in Bioanalytics - A Backstreet View of the “Fit for Purpose” Picture

    Keynote Speaker: Nancy Sajjadi, M.Sc. – Sajjadi Consulting

    Bioanalytics – Biomolecular

  • Keynote: How to Fulfil Requirements of FDA Guidance on Diversity of Clinical Trial Population? Perhaps by Translational Modelling

    Keynote Speaker: Amin Rostami, PhD – University of Manchester/ Certara

    Preclinical Development – Chemical

  • Keynote: Human Organs-on-Chips: From experimental models to clinical mimicry

    Keynote Speaker: Donald Ingber, MD, PhD – Wyss Institute for Biologically Inspired Engineering at Harvard

    Preclinical Development – Biomolecular

  • Keynote: Immune Stimulating Antibody Conjugates – Manufacturing and Analytical Considerations

    Keynote Speaker: Nathan Ihle, PhD – Bolt Biotherapeutics

    Manufacturing and Analytical Characterization – Biomolecular

  • Keynote: Innovations in biological modalities - meeting challenges in translation and development to unlock opportunity for patients

    Keynote Speaker: Justin Scheer, PhD – Janssen

    Preclinical Development – Biomolecular

  • Keynote: Nanotechnology and Biotechnology: new hopes and realities

    Keynote Speaker: Maria J. Alonso, PhD – University of Santiago de Compostela

    Formulation and Delivery – Biomolecular

  • Keynote: New Materials for the Delivery of Cells, RNA, and Genome Editing Tool

    Keynote Speaker: Dan Anderson, PhD – Massachusetts Institute of Technology

    Formulation and Delivery – Biomolecular

  • Keynote: Nonclinical Safety Assessment for GalNAc-conjugated Antisense Oligonucleotides

    Keynote Speaker: Tae-Won Kim, PhD – Ionis Pharmaceuticals, Inc.

    Preclinical Development – Chemical

  • Keynote: Opportunities for Non-liquid Matrices in Today's Pharma

    Keynote Speaker: Chad J. Briscoe, PhD – BioAgilytix Labs

    Bioanalytics – Chemical

  • Keynote: Pharmacokinetics and Pharmacodynamics of Non-Intravenous Delivery Routes for Biologics

    Keynote Speaker: Donald E. Mager, PharmD, PhD, FAAPS – University at Buffalo, SUNY

    Clinical Pharmacology – Biomolecular

  • Keynote: Reproducibility for Complicated NGS Analyses: Keeping Clouds in Bottles

    Keynote Speaker: David A. Shivak, MSc – Sangamo Therapeutics

    Bioanalytics – Biomolecular

  • Keynote: Tentative Title: Novel Delivery Systems, the Needs and Challenges of Leveraging Advanced Analytical Tools

    Keynote Speaker: Justin Pennington, PhD – Merck Research Laboratories

    Manufacturing and Analytical Characterization – Chemical

  • Keynote: Testing Thousands of Chemically Distinct Nanoparticles in vivo Using DNA Barcodes

    Keynote Speaker: James Dahlman, PhD – Georgia Tech / Emory Med School

    Discovery and Basic Research

  • Keynote: Towards the Implementation of Patient Centric Blood Sampling and Analysis as a Routine: Working as a Community

    Keynote Speaker: Neil Spooner, PhD, CChem, FRSC – Spooner Bioanalytical Solutions

    Bioanalytics – Chemical

  • Keynote: TRAIL-Coated Leukocytes that Target Circulating Tumor Cells in Concert with Fluid Forces

    Keynote Speaker: Michael R. King, PhD – Vanderbilt University

    Discovery and Basic Research

  • Keynote: Understanding of Bionanoscale Interactions as the Route to Systemic Targeted Therapeutics: Time for (Cautious) Optimism

    Keynote Speaker: Kenneth Dawson, PhD – University College Dublin

    Discovery and Basic Research

  • Large-Scale Mass Spectrometry Profiling: Accelerated Biomarker Discovery Drives Drug Development

    Tech Challenge Speaker: Mohit Jain, MD, PhD – Sapient

    Bioanalytics

  • Leadership and Management Skills for Pharmaceutical Scientists: Make Better Decisions

    Career Center Speaker: Susan Morris, M.Ed., CPCC, ACC – Susan Morris Coaching

    Career Development

  • Liver-Chips: Qualifying a Preclinical Model System for AAV Vector Development

    Partner Presentation Speaker: S. Jordan Kerns, PhD – Emulate, Inc.

    Preclinical Development

  • Magnetic Resonance: Benchtop Solutions for the Pharmaceutical Industry

    Tech Challenge Speaker: Kate Holub, MS MBA – Bruker BioSpin

    Manufacturing and Analytical Characterization

  • Metamorphosis of Topical Semi-solids: Microstructural Changes & Dermal Drug Delivery

    Partner Presentation Speaker: Benjamin C. Goodyear, PhD – BASF Corporation

    Partner Presentation Speaker: S. Narasimha Murthy, Ph.D. – Institute for Biomedical Drug Delivery Research

    Formulation and Delivery

  • Navigating Non-Traditional Scientific Careers: From Bench to Board Room

    Career Center Moderator: Shraddha Thakkar, PhD – US Food and Drug Administration

    Career Center Speaker: Syril Pettit, DrPH, MEM – HESI

    Career Center Speaker: Maaike Everts, PhD – Evonik Health Care

    Career Center Moderator: Brian Dow, PhD – Janssen Research & Development, LLC

    Career Center Speaker: Tina S. Morris, PhD – AAPS

    Career Development

  • Need-Based Dosing Solutions for Special Patient Populations

    Tech Challenge Speaker: SRINIVASAN SHANMUGAM, PhD – Adare Pharma Solutions

    Formulation and Delivery

  • Nitrosamines UPLC Method Development using Analytical Quality by Design Software

    Partner Presentation Speaker: Fadi Alkhateeb – Waters Corporation

    Partner Presentation Speaker: Nathan Anderson, MS, MBA – Waters Corporation

  • Non CYP-Mediated Metabolism Pathways and In Vitro Evaluation Strategies

    Partner Presentation Speaker: Andrew G. Taylor – SEKISUI XenoTech

    Manufacturing and Analytical Characterization

  • Prologue: Achievements/Gaps: Where are We With the Transporter in IVIVE-PBPK Modeling

    Prologue Speaker: Sibylle Neuhoff, PhD – Certara UK Limited

    Clinical Pharmacology – Chemical

  • Prologue: Achieving Dichotomous Goals for Drug Delivery – Challenges with Scalability and Target Specificity

    Prologue Speaker: Vivek Gupta, PhD – St. John's University

    Discovery and Basic Research

  • Prologue: Advances in Inhaled Nanosystem Formulations: Design and Development

    Prologue Speaker: Heidi M. Mansour, PhD, R.Ph. – The University of Arizona

    Formulation and Delivery – Biomolecular

  • Prologue: Bioanalysis and the Oncology Revolution

    Prologue Speaker: Enaksha Wickremsinhe, PhD – Eli Lilly and Company

    Bioanalytics – Biomolecular

  • Prologue: Bioanalysis for Cell Based Therapies

    Prologue Speaker: Piotr L. Pierog, PhD – Precision and Translational Medicine

    Bioanalytics – Biomolecular

  • Prologue: Bioanalysis of Non-Liquid Matrices: Science, Technology, and Assay Quality

    Prologue Speaker: Faye Vazvaei, M.S. – Merck & Co., Inc.

    Bioanalytics – Chemical

  • Prologue: Bioanalytical Complexities in Support of Multi-Specific Therapeutics

    Prologue Speaker: Kelly S. Colletti, PhD, MBA – Charles River Laboratories

    Bioanalytics – Biomolecular

  • Prologue: Biomaterials - An Immunometabolism Modulating Tool

    Prologue Speaker: Abhinav Acharya, PhD – Arizona State University

    Discovery and Basic Research

  • Prologue: Current Trends in Protein Degrader Technology

    Prologue Speaker: Steven Louie, MS – Novartis

    Discovery and Basic Research

  • Prologue: Essential Performance Requirements for Combination Products

    Prologue Speaker: John K. Towns, PhD – Eli Lilly and Company

    Manufacturing and Analytical Characterization – Chemical

  • Prologue: Evaluation of Excipient Variability to Support QbD Formulation Development

    Prologue Speaker: Pauline Janssen, MSc – DFE Pharma - Goch

    Formulation and Delivery – Chemical

  • Prologue: Evolution in Our Understanding of Excipients in the Formulation of Biologics

    Prologue Speaker: Robin Bogner, PhD – University of Connecticut

    Formulation and Delivery – Biomolecular

  • Prologue: Human Pharmacokinetics Prediction: Much Better, But There's More to Do!

    Prologue Speaker: Shobha Bhattachar, M. Pharm, MS – Eli Lilly and Company

    Preclinical Development – Chemical

  • Prologue: Innovations in High Throughput Screening of Therapeutic Carriers

    Prologue Speaker: Xiaoshu Pan, Ph.D. – University of Florida

    Discovery and Basic Research

  • Prologue: Introducing Open Innovation Challenge: Subcutaneous Drug Delivery and Development Consortium

    Prologue Speaker: Sachin Mittal, PhD – Merck & Co., Inc.

    Formulation and Delivery – Biomolecular

  • Prologue: Long-Acting-Drug-Delivery: State of the Art in Chemistry, Processing and Formulation

    Prologue Speaker: Sean McMahon, B.Eng, M.Sc, Ph.D – Ashland Specialty Ingredients

    Formulation and Delivery – Chemical

  • Prologue: Machine and Deep Learning in Pharmaceutical Manufacturing

    Prologue Speaker: Daniel Skomski, PhD – MRL Merck & Co., Inc.

    Manufacturing and Analytical Characterization – Chemical

  • Prologue: Managing Organic Impurities to Support Drug Product Lifecycle

    Prologue Speaker: Yong Liu, PhD – Merck & Co., Inc.

    Manufacturing and Analytical Characterization – Chemical

  • Prologue: MIDD in Preclinical Drug Development

    Prologue Speaker: Neil A. Miller, MSc – Simulations Plus

    Preclinical Development – Chemical

  • Prologue: Novel Approaches to Manage Immunogenicity of Biotherapeutics

    Prologue Speaker: Kuo-Ching Mei, MRes, PhD, MRSC – UNC Eshelman School of Pharmacy

    Discovery and Basic Research

  • Prologue: Novel Biomaterials in Cancer Immunotherapy

    Prologue Speaker: Mei He, PhD – University of Florida

    Discovery and Basic Research

  • Prologue: Opportunities for Application of Model Informed Approaches for Novel Modalities

    Prologue Speaker: Ganesh Mugundu, M.Pharm PhD – Takeda

    Clinical Pharmacology

  • Prologue: Optimizing Patient Outcome with Prevention and Mitigation Strategies for Immunogenicity of Therapeutic Protiens

    Prologue Speaker: Amy S. Rosenberg, MD – EpiVax, Inc

    Preclinical Development – Biomolecular

  • Prologue: Overcoming Challenges to Successful Rare Disease Drug Early Clinical Development: A Quantitative Pharmacology Perspective

    Prologue Speaker: Tong Zhu, PhD – Pfizer Inc

    Clinical Pharmacology – Biomolecular

  • Prologue: Patient Centric Formulation Development: Tales of Evolving Pipelines and Drug Delivery Solutions

    Prologue Speaker: Erin Guidry, PhD – Merck

    Formulation and Delivery – Chemical

  • Prologue: Preclinical Development – Biomolecular

    Prologue Speaker: Nagendra Chemuturi, GDMPK – Takeda

    Preclinical Development – Biomolecular

  • Prologue: Predictive or Non-Predictive, What Works for Special Delivery Routes?

    Prologue Speaker: Catherine A. Fromen, PhD – University of Delaware

    Clinical Pharmacology – Chemical

  • Prologue: Role of Clinical Pharmacology in Rare and Neglected Diseases and Special Populations

    Speaker: Jaya Vaidyanathan, PhD – Division of Cardiometabolic and Endocrine Pharmacology, OCP/OTS/CDER/US Food and Drug Administration

    Clinical Pharmacology – Chemical

  • Prologue: Subcutaneous Delivery of Protein Therapeutics

    Prologue Speaker: Manuel Sanchez-Felix, PhD – Novartis

    Preclinical Development – Biomolecular

  • Prologue: The Evolving World of Bioanalysis

    Bioanalytics – Chemical

  • Prologue: Understanding Biologics Product- and Process-Related Impurities Along the Product Lifecycle

    Prologue Speaker: Jianmei D. Kochling, PhD, MBA. – Sanofi

    Manufacturing and Analytical Characterization – Biomolecular

  • Pronunciation Powerhouse: Making your Words Heard
  • Quantifying Intact Proteins and Complex Structures Using High-resolution Mass Spectrometry

    Tech Challenge Speaker: Shane R. Needham, PhD – Alturas Analytics Inc

    Bioanalytics

  • Rapid Fire: Advancements in Chemical Knockdowns of Disease-Relevant Targets

    Discovery and Basic Research

  • Rapid Fire: Advances in Manufacturing and Analytical Characterization Working with Novel Therapeutic and Delivery Systems (BM)

    Manufacturing and Analytical Characterization – Biomolecular

  • Rapid Fire: Advances in Manufacturing and Analytical Characterization Working with Novel Therapeutic and Delivery Systems (CE)

    Manufacturing and Analytical Characterization – Chemical

  • Rapid Fire: Applications for Predictive and Clinically Relevant In Vitro, Ex-Vivo and In Vivo Models (BM)

    Preclinical Development – Biomolecular

  • Rapid Fire: Applications for Predictive and Clinically Relevant In Vitro, Ex-Vivo and In Vivo Models (CE)

    Preclinical Development – Chemical

  • Rapid Fire: Best Practices in Bioanalysis (BM)

    Bioanalytics – Biomolecular

  • Rapid Fire: Best Practices in Bioanalysis (CE)

    Bioanalytics – Chemical

  • Rapid Fire: Beyond the Bench (BM)

    Bioanalytics – Biomolecular

  • Rapid Fire: Beyond the Bench (CE)

    Bioanalytics – Chemical

  • Rapid Fire: Biomaterial-Focused Approaches for Immunomodulation

    Discovery and Basic Research

  • Rapid Fire: Challenges in Control Strategies for Drug Development (BM)

    Manufacturing and Analytical Characterization – Biomolecular

  • Rapid Fire: Challenges in Control Strategies for Drug Development (CE)

    Manufacturing and Analytical Characterization – Chemical

  • Rapid Fire: Clinical Pharmacology and Immunogenicity Considerations of Novel Modalities

    Clinical Pharmacology

  • Rapid Fire: Clinical Pharmacology Challenges and Opportunities in Rare and Neglected Diseases and Special Populations

    Clinical Pharmacology

  • Rapid Fire: Clinical Pharmacology Challenges of Special Delivery Routes

    Clinical Pharmacology

  • Rapid Fire: Delivery Systems for Effective Shuttling Across Biological Barriers (BM)

    Formulation and Delivery – Biomolecular

  • Rapid Fire: Delivery Systems for Effective Shuttling Across Biological Barriers (CE)

    Formulation and Delivery – Chemical

  • Rapid Fire: Design and Preclinical Development of Novel Therapeutic Modalities, Molecules and Delivery Approaches (BM)

    Preclinical Development – Biomolecular

  • Rapid Fire: Design and Preclinical Development of Novel Therapeutic Modalities, Molecules and Delivery Approaches (CE)

    Preclinical Development – Chemical

  • Rapid Fire: Formulation Development for New Therapeutic Modalities (BM)

    Formulation and Delivery – Biomolecular

  • Rapid Fire: Formulation Development for New Therapeutic Modalities (CE)

    Formulation and Delivery – Chemical

  • Rapid Fire: Innovations in High Throughput Screening of Therapeutic Carriers

    Discovery and Basic Research

  • Rapid Fire: Model-Informed Preclinical and Translational Drug Development (BM)

    Preclinical Development – Biomolecular

  • Rapid Fire: Model-Informed Preclinical and Translational Drug Development (CE)

    Preclinical Development – Chemical

  • Rapid Fire: New Opportunities in Modeling, Controls, and Analytics (BM)

    Manufacturing and Analytical Characterization – Biomolecular

  • Rapid Fire: New Opportunities in Modeling, Controls, and Analytics (CE)

    Manufacturing and Analytical Characterization – Chemical

  • Rapid Fire: Role of Excipients in Formulation & Drug Product Development (BM)

    Formulation and Delivery – Biomolecular

  • Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)

    Formulation and Delivery – Chemical

  • Rapid Fire: Systemic Drug and Gene Delivery -- Tackling the Challenges Head-On

    Discovery and Basic Research

  • Rapid Fire: The Evolving World of Bioanalysis (BM)

    Bioanalytics – Biomolecular

  • Rapid Fire: The Evolving World of Bioanalysis (CE)

    Bioanalytics – Chemical

  • Rapid Screening of Bioavailability Enhancing Technologies

    Partner Presentation Speaker: Brent Moody – Catalent

    Formulation and Delivery

  • Regulatory Approach to the Validation of PCR Assays

    Partner Presentation Speaker: Philip J. Kuehl, PhD – Lovelace Biomedical Research Institute

    Partner Presentation Speaker: Stephanie A. Pasas-Farmer, PhD – Ariande Software

    Bioanalytics

  • Resolving More Isoforms: LC System Volume Effects on IEX Chromatography

    Partner Presentation Speaker: Bob Giuffre, MS – Agilent Technologies

    Manufacturing and Analytical Characterization

  • Revolutionary Oral Targeted Drug Delivery of Sensitive Drugs

    Partner Presentation Speaker: Kamlesh Oza, Ph. D. – Evonik

    Formulation and Delivery

  • Structural Elucidation and Quantification of Small Molecule Pharmaceuticals and Impurities

    Partner Presentation Speaker: Christopher M. Crittenden, PhD – Genentech, Inc.

    Partner Presentation Speaker: Wael Elmasri, PhD – Thermo Fisher Scientific

    Manufacturing and Analytical Characterization

  • Symposium: Clinical Pharmacology Challenges and Opportunities in Rare and Neglected Diseases and Special Populations

    Clinical Pharmacology – Biomolecular

  • Symposium: Advancements in Chemical Knockdowns of Disease-Relevant Targets

    Discovery and Basic Research

  • Symposium: Advances in Manufacturing and Analytical Characterization Working with Novel Therapeutic and Delivery Systems (BM)

    Manufacturing and Analytical Characterization – Biomolecular

  • Symposium: Advances in Manufacturing and Analytical Characterization Working with Novel Therapeutic and Delivery Systems (CE)

    Manufacturing and Analytical Characterization – Chemical

  • Symposium: Applications for Predictive and Clinically Relevant In Vitro, Ex-Vivo and In Vivo Models (BM)

    Preclinical Development – Biomolecular

  • Symposium: Applications for Predictive and Clinically Relevant In Vitro, Ex-Vivo and In Vivo Models (CE)

    Preclinical Development – Chemical

  • Symposium: Best Practices in Bioanalysis

    Bioanalytics – Biomolecular

  • Symposium: Biomaterial-Focused Approaches for Immunomodulation

    Discovery and Basic Research

  • Symposium: Cancer Immunotherapy – What’s next?

    Discovery and Basic Research

  • Symposium: Challenges in Control Strategies for Drug Development (BM)

    Manufacturing and Analytical Characterization – Biomolecular

  • Symposium: Challenges in Control Strategies for Drug Development (CE)

    Manufacturing and Analytical Characterization – Chemical

  • Symposium: Clinical Pharmacology and Immunogenicity Considerations of Novel Modalities

    Clinical Pharmacology

  • Symposium: Clinical Pharmacology Challenges and Opportunities in Rare and Neglected Diseases and Special Populations

    Clinical Pharmacology – Chemical

  • Symposium: Clinical Pharmacology Challenges of Special Delivery Routes

    Clinical Pharmacology – Biomolecular

  • Symposium: Delivery Systems for Effective Shuttling Across Biological Barriers (BM)

    Formulation and Delivery – Biomolecular

  • Symposium: Delivery Systems for Effective Shuttling Across Biological Barriers (CE)

    Formulation and Delivery – Chemical

  • Symposium: Design and Preclinical Development of Novel Therapeutic Modalities, Molecules and Delivery Approaches

    Preclinical Development – Chemical